AquaBounty Technologies (NASDAQ:AQB) Trading Up 3.1%

AquaBounty Technologies, Inc. (NASDAQ:AQBGet Free Report)’s stock price rose 3.1% on Monday . The stock traded as high as $1.67 and last traded at $1.66. Approximately 18,292 shares changed hands during trading, a decline of 24% from the average daily volume of 23,926 shares. The stock had previously closed at $1.61.

Wall Street Analyst Weigh In

AQB has been the topic of a number of analyst reports. Oppenheimer reiterated a “market perform” rating on shares of AquaBounty Technologies in a research note on Tuesday, April 2nd. HC Wainwright reaffirmed a “neutral” rating on shares of AquaBounty Technologies in a report on Thursday, May 16th.

Read Our Latest Report on AQB

AquaBounty Technologies Trading Up 3.1 %

The stock has a fifty day simple moving average of $1.82 and a 200 day simple moving average of $2.11. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.23 and a current ratio of 0.26. The firm has a market cap of $6.41 million, a P/E ratio of -0.20 and a beta of 1.18.

AquaBounty Technologies (NASDAQ:AQBGet Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($1.53) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.42) by ($0.11). AquaBounty Technologies had a negative net margin of 1,263.43% and a negative return on equity of 16.07%. The company had revenue of $0.48 million for the quarter, compared to analysts’ expectations of $0.50 million. On average, research analysts expect that AquaBounty Technologies, Inc. will post -4.86 earnings per share for the current fiscal year.

AquaBounty Technologies Company Profile

(Get Free Report)

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.

Read More

Receive News & Ratings for AquaBounty Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AquaBounty Technologies and related companies with MarketBeat.com's FREE daily email newsletter.